Skip to main content
Home

Search form

  • ABOUT US
    • ECFS Society Details
      • Society Information
      • Applications for Support
    • ECFS Membership
      • Membership Subscription
      • Membership Demographics
    • Other Information
      • Latest News
      • Job Opportunities
      • Grants and Programmes
      • Links
  • RESEARCH
    • ECFS Projects
      • ECFS Clinical Trials Network
      • ECFS Patient Registry
    • ECFS Working Groups
      • Diagnostic Network
      • Exercise
      • Neonatal Screening
      • Fungal Pathogens
      • Pulmonary Exacerbation
    • Special Projects
      • ECFS / CF Europe Post-Doctoral Research Fellowship
      • CFQ-R questionnaire and CF candidates for lung transplant
      • EU funded projects
      • MucoFong International Project
      • Complete CFTR gene mutation analysis in European patients with Cystic Fibrosis
    • Past Working Groups
      • Cystic Fibrosis Molecular and Cell Biology and Physiology Basic Science
      • ECFS Gene Modifier Working Group
      • ECFS Non Tuberculous Mycobacteria Working Group
  • CARE
    • ECFS Standards Of Care
    • ECFS Working Groups
      • Exercise
      • Diagnostic Network
      • Neonatal Screening
      • Mental Health
      • Fungal Pathogens
      • Pulmonary Exacerbation
      • Telehealth
    • Allied Health Professionals
      • ECFS Nursing Special interest Group
      • European CF Pharmacy Group
      • European Cystic Fibrosis Nutrition Group
      • European Psychosocial Special Interest Group
      • ECFS Physiotherapy Special Interest International Group
  • EDUCATION
  • CONFERENCES & EVENTS
    • European Cystic Fibrosis Conference
    • ECFS Basic Science Conference
    • Related events
    • Past ECFS conferences
  • PUBLICATIONS
    • About Publications
      • The Journal of Cystic Fibrosis
      • ECFS Newsletter
      • ECFS Book
      • ERS Monograph
    • Resources
      • Search All Resources
      • CF Research News
      • Consensus Reports
      • ECFS Guidelines
      • Free Access Articles
      • CF Literature
  • MEMBERSHIP
  • LOG IN

continuous glucose monitoring

Comparing continuous glucose monitoring to self-monitoring of blood glucose in the management of cystic fibrosis related diabetes; a systematic review and meta-analysis

  • Read more about Comparing continuous glucose monitoring to self-monitoring of blood glucose in the management of cystic fibrosis related diabetes; a systematic review and meta-analysis

The effect of ETI (Trikafta™) on blood sugars in adults with cystic fibrosis

  • Read more about The effect of ETI (Trikafta™) on blood sugars in adults with cystic fibrosis

Elevated blood glucose during exacerbations of cystic fibrosis lung disease is associated with poor recovery of lung function.

  • Read more about Elevated blood glucose during exacerbations of cystic fibrosis lung disease is associated with poor recovery of lung function.

Comparing oral glucose tolerance test and continuous glucose monitoring

  • Read more about Comparing oral glucose tolerance test and continuous glucose monitoring

Early glucose abnormalities are associated with pulmonary inflammation in young children with cystic fibrosis

  • Read more about Early glucose abnormalities are associated with pulmonary inflammation in young children with cystic fibrosis

Early glucose abnormalities are associated with pulmonary inflammation in young children with cystic fibrosis

  • Read more about Early glucose abnormalities are associated with pulmonary inflammation in young children with cystic fibrosis

Early glucose abnormalities are associated with pulmonary inflammation in young children with cystic fibrosis

  • Read more about Early glucose abnormalities are associated with pulmonary inflammation in young children with cystic fibrosis

Continuous glucose monitoring in youth with cystic fibrosis treated with lumacaftor-ivacaftor

  • Read more about Continuous glucose monitoring in youth with cystic fibrosis treated with lumacaftor-ivacaftor

Quantifying fluctuation in glucose levels to identify early changes in glucose homeostasis in cystic fibrosis.

  • Read more about Quantifying fluctuation in glucose levels to identify early changes in glucose homeostasis in cystic fibrosis.
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)